Publié le 24/05/2024
Mission principale :
Dans le cadre de l’étude sur l’épigénétique des neutrophiles, la personne recrutée aura pour principale mission la gestion et l’analyse des prélèvements des patients atteints de cancer du poumon traités à l’ICM ou au CHU.
Date de prise de fonction 01.09.2024 Durée (CDD et détachements) CDD : 18 mois Renouvelable
Publié le 22/02/24
Application deadline: 31 Mars 2024
Anticipated start date: ASAP 2024
The team (Breast cancer, Microenvironment and Immunotargeting) at Montpellier Cancer Research
Institute (France) is looking for a postdoctoral researcher to work on the optimization of antibodydrug
conjugates targeting matricellular proteins in breast cancer. This postdoctoral fellowship is part
of a priority research program and equipment (PEPR) ACCREDIA, which brings together a lab network
of seven academic partners funded by the French government to improve knowledge, skills and
methodologies in antibody development. The position is funded in the frame of French PEPR-PIA4
Accredia ANR-22-PEBI-0009 for a period of 2 to 3 years.
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de